3177 results for «396»
3177 results
Most impactful trials in structural heart disease 2024/2025
30 Sep 2025 – From PCR Gulf Valves 2025
Delve into the most impactful structural heart disease trials shaping 2024 and 2025. This session addresses current dilemmas in TAVI, including early intervention and management of small annuli, evaluates evidence for transcatheter mitral and tricuspid valve repair, and identifies evidence gaps relevant to the region, providing...
Second valve strategies with SAPIEN 3 Ultra RESILIA
30 Sep 2025 – From PCR Gulf Valves 2025
Gain key insights into managing second valve interventions with the SAPIEN 3 Ultra RESILIA system.
This session helps you anticipate and address complex scenarios such as mitral valve-in-valve, TAV-in-SAV, and valve-in-valve-in-valve procedures. Learn from expert case discussions that explore procedural strategies, technical challenges, and best practices to...
Abstracts and challenging clinical cases
30 Sep 2025 – From PCR Gulf Valves 2025
Engage with a dynamic collection of abstracts and challenging clinical cases that highlight the latest advances and investigative studies in interventional cardiology. Topics include innovative approaches to aortic stenosis management, AI-powered procedural planning, hemodynamic insights beyond traditional imaging, and complex valve interventions, providing a comprehensive overview...
3D echocardiography for structural procedures
30 Sep 2025 – From PCR Gulf Valves 2025
This session provides an in-depth understanding of three-dimensional (3D) echocardiography in structural heart procedures. Learn how to optimize 3D echocardiographic imaging for various valve interventions, including mitral valve procedures, and gain practical skills through hands-on training to enhance procedural guidance and outcomes.
Complex femoral access for TAVI in bicuspid aortic stenosis - LIVE Case
30 Sep 2025 – From PCR Gulf Valves 2025
A 74-year-old male with a history of multiple PCIs, peripheral arterial disease, and type 2 DM presented with symptomatic bicuspid aortic stenosis and preserved LV function.
A 26 mm Myval valve was implanted via right femoral artery access, with right radial secondary access, following predilatation with a...
Echocardiography for mitral valvuloplasty ballooning
30 Sep 2025 – From PCR Gulf Valves 2025
Enhance your expertise in echocardiography assessment and intraprocedural guidance for mitral valvuloplasty ballooning. This session focuses on evaluating mitral stenosis, distinguishing suitable from non-suitable candidates, and offers practical, hands-on experience to optimize procedural outcomes using echocardiographic techniques.
PCR Gulf Valves 2025 Closing Ceremony
30 Sep 2025 – From PCR Gulf Valves 2025
Join the PCR Gulf Valves 2025 Closing Ceremony to reflect on the advancements and highlights of this year’s sessions dedicated to valvular interventions. This event marks the culmination of comprehensive educational activities, fostering collaboration and innovation in valvular heart disease management within the Gulf region.
PCR Gulf Valves 2025 Opening Ceremony
29 Sep 2025 – From PCR Gulf Valves 2025
Join us for the PCR Gulf Valves 2025 Opening Ceremony, marking the commencement of an exceptional congress dedicated to advances in structural heart interventions. This session sets the stage for the latest innovations and expert discussions that will shape the future of valve therapies in the...
Left main bifurcation - LIVE Case
30 Jan 2026 – From SASCI-AfricaPCR
Join this session if you want to understand and optimise treatment strategies for LM bifurcation lesions, specifically: Understanding LM bifurcation anatomy and physiology, choosing the best stent strategy, optimising stent deployment and results.
LIVE Case from Groote Schuur Hospital Cape Town
Calcified lesions - LIVE Case
30 Jan 2026 – From SASCI-AfricaPCR
Watch this session if you want to understand the challenges and risks when treating calcified lesions, to learn how to accurately assess coronary calcification, to learn how to utilise the tools available for treating calcified lesions.
LIVE Case from Groote Schuur Hospital Cape Town
Design that delivers the future of TAVI
13 Feb 2026 – From PCR Tokyo Valves 2026
This session presents the future of TAVI valve design, emphasizing supra-annular valve benefits, strategies for managing concomitant coronary artery disease, and redo-TAVI approaches tailored for long-term patient management.
We CARE in 2023: Measuring the pandemic’s impact and developing tools to build resilience for the future
18 May 2023
The COVID-19 pandemic caused huge disruption to healthcare services and dramatically reduced hospital admissions for MI.1 In response, the We CARE initiative was created from a collaboration between PCR and Stent – Save a Life! to rebuild patient confidence in pursuing timely medical treatment and to help...
We CARE about hearts - EuroPCR 2022
19 May 2022
The aims of We CARE are to rebuild patient confidence and help stakeholders provide effective and timely cardiac care through knowledge, education and training.
Author
We CARE: a joint initiative by PCR and Stent – Save a Life!
07 May 2021
Paris, France. Since the start of the COVID-19 pandemic, patients have been consistently deprived of timely cardiovascular treatment. This is due in part to measures taken in response to the sanitary crisis, but it is also due to patients' own unwillingness to seek medical help, even...
RADIANCE-HTN: Six-Month Outcomes of a Randomized Trial of Renal Denervation Versus a Sham Procedure for Resistant Hypertension – Impact of Treatment-Blinded Medication Titration
04 Nov 2021
Panos Xaplanteris review the RADIANCE-HTN Study, presented by Ajay Kirtane, an international randomized, sham-controlled clinical trial evaluating the safety and efficacy of renal denervation (RDN) in a population of treatment-resistant hypertensive patients.
Author
TAILORED-CHIP: Tailored antiplatelet therapy for complex high-risk PCI
29 Aug 2025
Nicola Ryan provides her take on the results of TAILORED-CHIP presented by Duk-Woo Park at the ESC Congress 2025 in Madrid.
Author
Insights from the Corevalve US Pivotal and SURTAVI trials
05 Apr 2022
Pierre Deharo and Giuseppe Di Gioia provide their take on this analysis of the 5 years incidence, outcomes and predictors of hemodynamic SVD in patients undergoing TAVI and surgery from the Corevalve US Pivotal and SURTAVI trials.
Author
Author
